Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
Cancer Treatment Reports
|
September 1, 1986
Association of severe and fatal infections and treatment with pentostatin
P J O'Dwyer, A S Spiers, S Marsoni
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1982
Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin
J S Macdonald, S Marsoni, S Bruno, et al.
Cancer Treatment Reviews
|
March 1, 1991
Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results
C Sessa, N Colombo, G Bolis, et al.
Epidemiologia E Prevenzione
|
March 1, 1994
[Comorbidity and the physician's decision: the case of undertreatment in care of breast tumors]
G Bertolini, G Apolone, A Liberati, et al.
Cancer Treatment Reports
|
November 1, 1985
The phase II trial
R E Wittes, S Marsoni, R Simon, et al.
Cancer Treatment Reports
|
December 1, 1984
Teniposide: a review of 12 years of experience
P J O'Dwyer, M T Alonso, B Leyland-Jones, et al.
Cancer Clinical Trials
|
January 1, 1980
Bis-diketopiperazine derivatives in clinical oncology: ICRF-159
D S Poster, J Penta, S Marsoni, et al.
Medical Care
|
January 1, 1991
The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy
R Grilli, G Apolone, S Marsoni, et al.
Cancer Treatment Reports
|
August 1, 1986
Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?
B J Foster, K Clagett-Carr, S Marsoni, et al.
Cancer Treatment Reports
|
September 1, 1986
Therapeutic response in phase I trials of antineoplastic agents
E Estey, D Hoth, R Simon, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
Cancer Treatment Reports
|
September 1, 1986
Association of severe and fatal infections and treatment with pentostatin
P J O'Dwyer, A S Spiers, S Marsoni
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1982
Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin
J S Macdonald, S Marsoni, S Bruno, et al.
Cancer Treatment Reviews
|
March 1, 1991
Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results
C Sessa, N Colombo, G Bolis, et al.
Epidemiologia E Prevenzione
|
March 1, 1994
[Comorbidity and the physician's decision: the case of undertreatment in care of breast tumors]
G Bertolini, G Apolone, A Liberati, et al.
Cancer Treatment Reports
|
November 1, 1985
The phase II trial
R E Wittes, S Marsoni, R Simon, et al.
Cancer Treatment Reports
|
December 1, 1984
Teniposide: a review of 12 years of experience
P J O'Dwyer, M T Alonso, B Leyland-Jones, et al.
Cancer Clinical Trials
|
January 1, 1980
Bis-diketopiperazine derivatives in clinical oncology: ICRF-159
D S Poster, J Penta, S Marsoni, et al.
Medical Care
|
January 1, 1991
The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy
R Grilli, G Apolone, S Marsoni, et al.
Cancer Treatment Reports
|
August 1, 1986
Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?
B J Foster, K Clagett-Carr, S Marsoni, et al.
Cancer Treatment Reports
|
September 1, 1986
Therapeutic response in phase I trials of antineoplastic agents
E Estey, D Hoth, R Simon, et al.
Page
of 7